Vaxart Inc (VXRT)
0.7289
-0.02
(-2.68%)
USD |
NASDAQ |
May 03, 16:00
0.7419
+0.01
(+1.78%)
After-Hours: 20:00
Vaxart Gross Profit (Quarterly)
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2015 | 1.70M |
| June 30, 2015 | 4.10M |
| March 31, 2015 | 5.60M |
| December 31, 2014 | 12.30M |
| September 30, 2014 | -1.00M |
| June 30, 2014 | -1.30M |
| March 31, 2014 | 10.20M |
| December 31, 2013 | 7.10M |
| September 30, 2013 | 1.60M |
| June 30, 2013 | 2.285M |
| March 31, 2013 | 8.402M |
| December 31, 2012 | 3.298M |
| September 30, 2012 | 0.632M |
| June 30, 2012 | |
| March 31, 2012 | 0.632M |
| December 31, 2011 | 0.89M |
| September 30, 2011 | 0.742M |
| June 30, 2011 | 3.195M |
| March 31, 2011 | 8.548M |
| December 31, 2010 | 2.257M |
| September 30, 2010 | 11.49M |
| June 30, 2010 | 4.234M |
| March 31, 2010 | 13.07M |
| December 31, 2009 | 8.501M |
| September 30, 2009 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
| December 31, 2008 | |
| September 30, 2008 | |
| June 30, 2008 | |
| March 31, 2008 | |
| December 31, 2007 | |
| September 30, 2007 | 5.416M |
| June 30, 2007 | |
| March 31, 2007 | 9.009M |
| December 31, 2006 | |
| September 30, 2006 | 4.206M |
| June 30, 2006 | 6.008M |
| March 31, 2006 | 5.069M |
| December 31, 2005 | |
| September 30, 2005 | 8.864M |
| June 30, 2005 | 10.03M |
| March 31, 2005 | 9.015M |
| December 31, 2004 | -29.22M |
| September 30, 2004 | 26.28M |
| June 30, 2004 | 30.52M |
| March 31, 2004 | 22.57M |
| December 31, 2003 | 43.12M |
| September 30, 2003 | 20.91M |
| June 30, 2003 | 14.54M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Quarterly) Benchmarks
| Novavax Inc | 98.42M |
| aTyr Pharma Inc | -- |
| Allogene Therapeutics Inc | -- |
| AIM ImmunoTech Inc | 0.053M |
| Protalix BioTherapeutics Inc | 1.63M |